Health + Biotechnology
Advance well-being in a city
driving health innovation
Brampton is home to a fast-growing Health + Biotechnology ecosystem supported by major hospitals, global life science firms, and world-class post-secondary programs focused on integrated health, prevention, and medical technology.
by Brampton's industry
in Brampton's industry
Discover Brampton
Providing world-class healthcare in a state-of-the-art environment
- Brampton’s Health + Biotechnology workforce is supported by a strong educational ecosystem, including Sheridan College and proximity to the University of Toronto Mississauga and McMaster’s health sciences programs. Since 2006, life science program enrollment in the region has tripled, feeding a growing need for clinical researchers, medical technologists, and digital health specialists.
- Ontario offers unique innovation supports such as the Ontario Bioscience Innovation Organization (OBIO) and the Health Innovation Hub (H2i), connecting academic research with commercialization.
- Brampton’s health ecosystem spans clinical care, diagnostics, pharmaceuticals, and medical devices. Its business landscape includes multinationals like Medtronic and Taro Pharmaceuticals, as well as fast-growing SMEs in biotech and healthtech. These firms benefit from Brampton’s proximity to the Toronto-Waterloo Innovation Corridor and access to healthcare-focused logistics infrastructure.
- Ontario is home to over 1,900 life sciences firms and contributes nearly half of Canada’s total health R&D activity. At federal level, Health Canada and Canadian Institutes of Health Research (CIHR) continue to invest, helping drive economic resilience and sector growth.
- The new Peel Memorial Centre for Integrated Health & Wellness is the catalyst for Brampton’s emerging Health & Biotech Cluster. This downtown innovation zone emphasizes preventive health, population analytics, and app-based health tools – creating opportunities for entrepreneurs working in AI, digital, and community wellness.
- Looking ahead, Ontario’s Health + Biotechnology sector is embracing advances in genomics, wearable diagnostics, and regenerative medicine. With coordinated investment across public, academic, and private partners, Brampton is positioned to become a nationally recognized hub for innovation in aging care and medical technology.
How we help
BHive’s Health + Biotechnology Cohort offers a number of key benefits for international start-ups, including:
Access to
Funding
Matching applicants with suitable investors and funding opportunities.
Skilled
Talent
Access to a skilled local workforce of technology professionals as well as thousands of students enrolled at the 21 post-secondary institutions located near Brampton.
Mentorship Opportunities
Introductions to leaders in the HealthTech space to provide mentorship, guidance and support.
Research Facilities
+ Lab Space Access
Leveraging resources from one of the 21 post-secondary institutions located within an hour’s drive of Brampton, including top-rated research universities in North America like McMaster University & University of Toronto.
Dedicated Sector Manager
Access to a dedicated Sector Manager specializing in HealthTech to provide industry-specific advice for the Canadian and North American markets.
Who should apply
Our Healthcare cohort is suited to future-thinking, coachable founders building proprietary technologies, advanced research, complex models, and unique designs to innovate healthcare for hospitals, nursing homes, long-term care centres, hospices, patients, and their families.
This cohort is aimed toward early-stage companies (pre-seed, seed, or series), whether they have raised little to no investment or even projects (pre-incorporation); however, start-ups at all levels of the company life cycle will be considered.
Companies with any or all of the following are preferred:
- IP
- Patent
- Published research
- FDA approved
- Government approved
- Clinical trials completion
- Biotech and bioinformatics
- Diagnostics
- Medicine
- Wellness and mental health
- Psychotherapy and Psychodelics
- Drug development
- Cognition
